329,923 results
-
Plasmid#38776DepositorAvailable SinceDec. 13, 2012AvailabilityAcademic Institutions and Nonprofits only
-
phOct4-EGFP
Plasmid#38776DepositorAvailable SinceDec. 13, 2012AvailabilityAcademic Institutions and Nonprofits only -
Human V5-IRF3-pcDNA3
Plasmid#32713DepositorAvailable SinceMarch 2, 2012AvailabilityAcademic Institutions and Nonprofits only -
Human V5-IRF3-pcDNA3
Plasmid#32713DepositorAvailable SinceMarch 2, 2012AvailabilityAcademic Institutions and Nonprofits only -
pJV53
Plasmid#26904DepositorInsertChe9c genes 60-61
ExpressionBacterialAvailable SinceFeb. 22, 2012AvailabilityAcademic Institutions and Nonprofits only -
pJV53
Plasmid#26904DepositorInsertChe9c genes 60-61
ExpressionBacterialAvailable SinceFeb. 22, 2012AvailabilityAcademic Institutions and Nonprofits only -
pNANOG-Luc
Plasmid#25900DepositorAvailable SinceAug. 5, 2010AvailabilityAcademic Institutions and Nonprofits only -
pNANOG-Luc
Plasmid#25900DepositorAvailable SinceAug. 5, 2010AvailabilityAcademic Institutions and Nonprofits only -
PT2/C-Luc//PGK-SB13
Plasmid#20207DepositorInsertFlirefly luciferase/Sb transposase
UseTransposonAvailable SinceDec. 3, 2009AvailabilityAcademic Institutions and Nonprofits only -
PT2/C-Luc//PGK-SB13
Plasmid#20207DepositorInsertFlirefly luciferase/Sb transposase
UseTransposonAvailable SinceDec. 3, 2009AvailabilityAcademic Institutions and Nonprofits only -
pLenti-CaMKIIa-hChR2(H134R)-mCherry-WPRE
Plasmid#20943Purpose3rd gen lentiviral expression of humanized ChR2 with H134R mutation fused to mCherry driven by CaMKIIa promoter for optogenetic activationDepositorInsertchannelrhodopsin-2
UseLentiviralTagsmCherryExpressionMammalianMutationH134RPromoterCaMKIIaAvailable SinceJuly 9, 2009AvailabilityAcademic Institutions and Nonprofits only -
pLenti-CaMKIIa-hChR2(H134R)-mCherry-WPRE
Plasmid#20943Purpose3rd gen lentiviral expression of humanized ChR2 with H134R mutation fused to mCherry driven by CaMKIIa promoter for optogenetic activationDepositorInsertchannelrhodopsin-2
UseLentiviralTagsmCherryExpressionMammalianMutationH134RPromoterCaMKIIaAvailable SinceJuly 9, 2009AvailabilityAcademic Institutions and Nonprofits only -
pHJ421
Plasmid#20680DepositorAvailable SinceMarch 24, 2009AvailabilityAcademic Institutions and Nonprofits only -
pHJ421
Plasmid#20680DepositorAvailable SinceMarch 24, 2009AvailabilityAcademic Institutions and Nonprofits only -
pRK5-HA-Ubiquitin-K29R
Plasmid#17602PurposeMammalian expression of HA tagged ubiquitin K29RDepositorAvailable SinceMarch 31, 2008AvailabilityAcademic Institutions and Nonprofits only -
pRK5-HA-Ubiquitin-K29R
Plasmid#17602PurposeMammalian expression of HA tagged ubiquitin K29RDepositorAvailable SinceMarch 31, 2008AvailabilityAcademic Institutions and Nonprofits only -
pPGK-Cre-bpA
Plasmid#11543PurposeExpresses Cre recombinase from mouse PGK promoter in mammalian cells.DepositorInsertPhosphoglycerate kinase 1 promoter
UseCre/LoxExpressionMammalianPromotermouse PGKAvailable SinceMay 25, 2006AvailabilityAcademic Institutions and Nonprofits only -
pPGK-Cre-bpA
Plasmid#11543PurposeExpresses Cre recombinase from mouse PGK promoter in mammalian cells.DepositorInsertPhosphoglycerate kinase 1 promoter
UseCre/LoxExpressionMammalianPromotermouse PGKAvailable SinceMay 25, 2006AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-EGFP (AAV Retrograde trial size)
Viral Prep#50465-AAVrg.TPurposeReady-to-use AAV Retrograde trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons.DepositorPromoterSynTagsEGFPAvailable SinceJuly 12, 2019AvailabilityAcademic Institutions and Nonprofits only -
pAAV-EF1a-fDIO-Cre (AAV Retrograde)
Viral Prep#121675-AAVrgPurposeReady-to-use AAV Retrograde particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceMay 31, 2019AvailabilityAcademic Institutions and Nonprofits only